Literature DB >> 24328767

β-Adrenoceptor genotype and bronchoprotective subsensitivity with long-acting β-agonists in asthma.

Brian Lipworth1.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24328767     DOI: 10.1164/rccm.201311-1968ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.

Authors:  Steve Turner; Ben Francis; Susanne Vijverberg; Maria Pino-Yanes; Anke H Maitland-van der Zee; Kaninika Basu; Lauren Bignell; Somnath Mukhopadhyay; Roger Tavendale; Colin Palmer; Daniel Hawcutt; Munir Pirmohamed; Esteban G Burchard; Brian Lipworth
Journal:  J Allergy Clin Immunol       Date:  2016-01-07       Impact factor: 10.793

2.  ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.

Authors:  Leila Karimi; Susanne J Vijverberg; Marjolein Engelkes; Natalia Hernandez-Pacheco; Niloufar Farzan; Patricia Soares; Maria Pino-Yanes; Andrea L Jorgensen; Celeste Eng; Somnath Mukhopadhyay; Maximilian Schieck; Michael Kabesch; Esteban G Burchard; Fook Tim Chew; Yang Yie Sio; Uroš Potočnik; Mario Gorenjak; Daniel B Hawcutt; Colin N Palmer; Steve Turner; Hettie M Janssens; Anke H Maitland-van der Zee; Katia M C Verhamme
Journal:  Clin Exp Allergy       Date:  2021-07-20       Impact factor: 5.401

3.  Is Gly16Arg β2 Receptor Polymorphism Related to Impulse Oscillometry in a Real-Life Asthma Clinic Setting?

Authors:  Sunny Jabbal; Arvind Manoharan; Joseph Lipworth; William Anderson; Philip Short; Brian Lipworth
Journal:  Lung       Date:  2016-02-15       Impact factor: 2.584

Review 4.  Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for "Omics" Technology?

Authors:  Carla Galeone; Chiara Scelfo; Francesca Bertolini; Marco Caminati; Patrizia Ruggiero; Nicola Facciolongo; Francesco Menzella
Journal:  Biomed Res Int       Date:  2018-06-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.